E Fund Management Co., Ltd. Biocryst Pharmaceuticals Inc Call Options Transaction History
E Fund Management Co., Ltd.
- $2.07 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCRX
# of Institutions
292Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$186 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$172 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$76.8 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$74.8 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$67.2 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.6B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...